Condition
Hypernasality
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05492266Not ApplicableRecruiting
Expiratory Muscle Strength Training for Hypernasal Speech in Children
NCT05273853Not ApplicableUnknownPrimary
Speech Outcome After Partial Adenoidectomy in Patients With Risk of Hypernasality
NCT03604822Not ApplicableUnknown
Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS
Showing all 3 trials